Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
2
institutions
Market cap
$7.1B
13M shares
52-week range
$365.21 – $557.00
87% from low
Sector
SERVICES-HOME HEALTH CARE SERVICES
Exchange
NYSE
CS
Chemed Corp purchases, operates, and divests subsidiaries engaged in diverse business activities to maximize shareholder value. The company operates in the following segments: VITAS and Roto-Rooter. The VITAS segment generates the majority of the firm's revenue and provides hospice and palliative care services to patients with terminal illnesses through a network of physicians, registered nurses, home health aides, social workers, and volunteers. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration, and related services to residential and commercial customers.
www.chemed.comNo one on the platform currently holds CHE.
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 12,340 | $4.7M |
| Bridgewater Associatesas of 2026-03-31 | 5,062 | $1.9M |
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-08-17 | $0.7000 | 2026-09-03 |
| 2026-05-28 | $0.6000 | 2026-06-16 |
| 2026-02-23 | $0.6000 | 2026-03-13 |
| 2025-11-17 | $0.6000 | 2025-12-05 |
| 2025-08-11 | $0.6000 | 2025-08-29 |
| 2025-05-29 | $0.5000 | 2025-06-17 |
| 2025-02-24 | $0.5000 | 2025-03-14 |
| 2024-11-18 | $0.5000 | 2024-12-06 |
| 2024-08-12 | $0.5000 | 2024-08-30 |
| 2024-05-30 | $0.4000 | 2024-06-18 |
No one on the platform has traded CHE yet.
| 2024-02-23 | $0.4000 | 2024-03-15 |
| 2023-11-10 | $0.4000 | 2023-12-04 |
| Execution date | Ratio |
|---|---|
| 2005-05-12 | 2-for-1 |
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $2.7B | +6.7% | $25.52 | $24.89–$26.16 | 20.9× | 2 |
| 2027 | $2.9B | +6.0% | $27.52 | $27.25–$27.80 | 19.4× | 2 |
| 2028 | $3.1B | +5.9% | $29.33 | $29.23–$29.38 | 18.2× | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 4 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-07-28 | $5.60 | $6.06 | +8.2% |
| 2026-04-23 | $5.30 | $5.65 | +6.6% |
| 2026-02-25 | $7.02 | $6.42 | -8.5% |
| 2025-10-28 | $5.39 | $5.27 | -2.2% |
| 2025-07-29 | $4.78 | $4.27 | -10.7% |
| 2025-04-23 | $5.55 | $5.63 | +1.4% |
| 2025-02-26 | $6.78 | $6.83 | +0.7% |
| 2024-10-29 | $5.76 | $5.64 | -2.1% |
| $11.5B |
| — |
| HSICHenry Schein, Inc. | $90.12 | -0.68% | $10.3B | — |
| MTSRMetsera, Inc. | $70.50 | -0.35% | $7.4B | — |
Source: Financial Modeling Prep · peers by sector/industry
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.
$CHE undiscovered breakout with 299 watchers
View on StockTwits ↗$CHE Q2 '26 Earnings Results & Recap • Reported GAAP EPS of $5.14 up 42.78% YoY • Reported revenue of $673.25M up 8.80% YoY • Chemed Corporation raised its full-year 2026 earnings per diluted share guidance to a range of $25.00 to $25.75, representing a 17.8% increase from 2025 adjusted earnings per diluted share.
View on StockTwits ↗$CHE Opportunity BofA Global Research raises price objective to $510.00 from $450.00
View on StockTwits ↗$CHE Selected for coverage by www.baorocapital.com. Target price = $850.
View on StockTwits ↗$CHE Put Open Interest Shifts for Chemed Corp This Week https://www.macroaxis.com/stock-options/CHE/Chemed-Corp?utm_source=dlvr.it&utm_medium=stocktwits
View on StockTwits ↗$CHE Really good write-up that perfectly summarizes CHE's present situation. So if you want to bring your CHE knowledge up to date or just discover CHE, this is required reading. https://everyticker.com/quote/CHE/analysis/chemed-s-asymmetric-turnaround-why-vitas-recovery-and-roto-rooter-resilience-make-this-dual-engine-story-compelling-nyse-che
View on StockTwits ↗Wall St is expecting 5.63 EPS for $CHE Q2 [Reporting 07/29 AMC] http://www.estimize.com/intro/che?chart=historical&metric_name=eps&utm_cont
View on StockTwits ↗Fundamental analysis of $CHE (CHEMED CORP) based on financial data and reported results. #CHE #CHEMED
View on StockTwits ↗$CHE (+8.4% pre) Chemed (CHE) Beats Q1 Earnings and Revenue Estimates https://ooc.bz/l/99915
View on StockTwits ↗After Hours Top Gainers PT2 $HKPD $TIVC $CISS $PDFS $CHE
View on StockTwits ↗$CHE Q1 '26 Earnings Results & Recap • Reported GAAP EPS of $4.85 down -1.22% YoY • Reported revenue of $657.51M up 1.63% YoY • Chemed raised full-year 2026 adjusted diluted EPS guidance to $24.00-$24.75, reflecting improved VITAS performance. However, Roto-Rooter's adjusted EBITDA margin guidance was lowered to 21.5%-22.5% due to elevated marketing costs.
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.